Oxford Biomedica PLC
A CDMO for cell & gene therapy, providing end-to-end viral vector development & manufacturing.
OXB | IL
Overview
Corporate Details
- ISIN(s):
- GB00BDFBVT43
- LEI:
- 213800S1GVQNXQ15K851
- Country:
- United Kingdom
- Address:
- WINDRUSH COURT, OX4 6LT OXFORD
- Website:
- https://www.oxb.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Oxford Biomedica PLC (OXB) is a global, innovation-led contract development and manufacturing organization (CDMO) specializing in cell and gene therapy. As a pioneer with over 30 years of experience, the company provides end-to-end services for the development and GMP manufacturing of viral vectors, including lentivirus, adeno-associated virus (AAV), and adenovirus. OXB supports pharmaceutical and biotechnology clients, from early-stage development to commercialization, through its global network of facilities in the UK, US, and France. The company leverages proprietary technology platforms, such as its commercially approved LentiVector™ and inAAVate™ systems, to enable the delivery of life-changing therapies.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-10-16 08:00 |
Director's Dealing
Director/PDMR Shareholding
|
English | 36.9 KB | ||
| 2025-10-01 08:00 |
Declaration of Voting Results & Voting Rights Announcements
Total Voting Rights
|
English | 11.6 KB | ||
| 2025-09-23 08:00 |
Earnings Release
Interim Results for 6 months ended 30 June 2025
|
English | 732.3 KB | ||
| 2025-08-22 16:36 |
Director's Dealing
PDMR Dealings
|
English | 29.1 KB | ||
| 2025-08-21 11:24 |
Major Shareholding Notification
Holding(s) in Company
|
English | 22.2 KB | ||
| 2025-08-20 08:00 |
Declaration of Voting Results & Voting Rights Announcements
Admission of Shares and Total Voting Rights
|
English | 10.9 KB | ||
| 2025-08-15 14:45 |
Director's Dealing
PDMR Dealings
|
English | 18.8 KB | ||
| 2025-08-15 08:05 |
Share Issue/Capital Change
Results of Placing
|
English | 43.5 KB | ||
| 2025-08-14 18:02 |
Share Issue/Capital Change
Proposed Placing of New Ordinary Shares
|
English | 168.6 KB | ||
| 2025-08-01 08:00 |
Capital/Financing Update
OXB Secures New Loan Facility with Oaktree
|
English | 16.3 KB | ||
| 2025-08-01 08:00 |
Declaration of Voting Results & Voting Rights Announcements
Total Voting Rights
|
English | 10.9 KB | ||
| 2025-07-28 08:00 |
Earnings Release
Half Year Trading Update
|
English | 23.8 KB | ||
| 2025-07-02 08:00 |
Board/Management Information
Director Declaration
|
English | 9.6 KB | ||
| 2025-06-23 08:00 |
M&A Activity
OXB completes acquisition of US subsidiary
|
English | 12.3 KB | ||
| 2025-06-17 19:00 |
Director's Dealing
Director/PDMR Shareholding
|
English | 18.8 KB |
Automate Your Workflow. Get a real-time feed of all Oxford Biomedica PLC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Oxford Biomedica PLC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Oxford Biomedica PLC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
